1. Kay, FU, Canan, A, Abbara, S. Common incidental findings on cardiac CT: a systematic review. Curr Cardiovasc Imaging Rep 2019; 12: 21.
Google Scholar | Crossref2. Chung, K, Mets, OM, Gerke, PK, et al. Brock malignancy risk calculator for pulmonary nodules: validation outside a lung cancer screening population. Thorax 2018; 73: 857–863.
Google Scholar | Crossref | Medline3. She, Y, Zhao, L, Dai, C, et al. Development and validation of a nomogram to estimate the pretest probability of cancer in Chinese patients with solid solitary pulmonary nodules: a multi-institutional study. J Surg Oncol 2017; 116: 756–762.
Google Scholar | Crossref | Medline4. Baldwin, DR, Callister, ME. The British Thoracic Society guidelines on the investigation and management of pulmonary nodules. Thorax 2015; 70: 794–798.
Google Scholar | Crossref | Medline5. Bai, C, Choi, C-M, Chu, CM, et al. Evaluation of pulmonary nodules: clinical practice consensus guidelines for Asia. Chest 2016; 150: 877–893.
Google Scholar | Crossref | Medline6. Phua, CK, Sim, WY, Tee, KS, et al. Evaluation of pulmonary nodules in Asian population. J Thorac Dis 2016; 8: 950, 957.
Google Scholar | Crossref | Medline7. MacMahon, H, Naidich, DP, Goo, JM, et al. Guidelines for management of incidental pulmonary nodules detected on CT images: from the Fleischner Society 2017. Radiology 2017; 284: 228–243.
Google Scholar | Crossref | Medline8. Sihoe, ADL, Hiranandani, R, Wong, H, et al. Operating on a suspicious lung mass without a preoperative tissue diagnosis: pros and cons. Eur J Cardiothorac Surg 2013; 44: 231–237.
Google Scholar | Crossref | Medline9. Panagiotidis, E, Alshammari, A, Michopoulou, S, et al. Comparison of the impact of 68Ga-DOTATATE and 18F-FDG PET/CT on clinical management in patients with neuroendocrine tumors. J Nucl Med 2017; 58: 91–96.
Google Scholar | Crossref | Medline10. Travis, WD, Brambilla, E, Nicholson, AG, et al. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol 2015; 10: 1243–1260.
Google Scholar | Crossref | Medline | ISI11. Hilal, T . Current understanding and approach to well differentiated lung neuroendocrine tumors: an update on classification and management. Ther Adv Med Oncol 2017; 9: 189–199.
Google Scholar | SAGE Journals | ISI12. Detterbeck, FC . Management of carcinoid tumors. Ann Thorac Surg 2010; 89: 998–1005.
Google Scholar | Crossref | Medline | ISI13. Phan, AT, Öberg, K, Choi, J, et al. NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the thorax (includes lung and thymus). Pancreas 2010; 39: 784–798.
Google Scholar | Crossref | Medline | ISI14. Hamad, A-M, Rizzardi, G, Marulli, G, et al. Nodal recurrence of pulmonary carcinoid 30 years after primary resection. J Thorac Oncol 2008; 3: 680–681.
Google Scholar | Crossref | Medline15. Oberg, K, Couvelard, A, Fave, G, et al. ENETS consensus guidelines for the standards of care in neuroendocrine tumors: biochemical markers. Neuroendocrinology 2017; 105: 201–211.
Google Scholar | Crossref | Medline16. Tirosh, A, Kebebew, E. The utility of 68Ga-DOTATATE positron-emission tomography/computed tomography in the diagnosis, management, follow-up and prognosis of neuroendocrine tumors. Future Oncol 2018; 14: 111–122.
Google Scholar | Crossref | Medline